Interim analysis results are reviewed

Interim analysis results are reviewed

The Data and Safety Monitoring Board (DSMB) reviews the results of the interim analysis. This is a critical point during the conduct of a clinical trial as the DSMB may recommend that the study be stopped the trial for futility in relation to the outcome. The DSMB recommends that the D2d study proceed to completion as planned. The D2d team is very pleased.


Leave a Reply

You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

D2d | Division of Endocrinology, Diabetes and Metabolism | Tufts Medical Center | Boston MA
Copyright © 2018 D2d study. All rights reserved.